pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
CRISPR/Cas9 · news · pharmadog
← back to CRISPR/Cas9
News · CRISPR/Cas9
99
stories
Jul 8, 26
Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal
biopharma dive
Jul 6, 26
Gene editing developer Scribe plots an IPO
biopharma dive
Jul 2, 26
Scribe Therapeutics files for IPO in test of appetite for early-stage biotechs
endpoints
Jul 2, 26
STAT+: A year after distressed buyout, what’s become of Bluebird Bio?
stat
Jul 1, 26
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
fda press
Jul 1, 26
BridgeBio gets funding for drug launch; United buys into cell therapy
biopharma dive
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 9, 26
Opinion: Ending animal testing could set back xenotransplantation just as the field is poised for a breakthrough
stat
Jun 4, 26
Scientists uncover a new hiding spot for HIV
stat
Jun 3, 26
Lilly, Ascidian link up in RNA exon editing pact
biopharma dive
Jun 1, 26
Epigenetic editing shows promise against chronic hep B infections
endpoints
May 28, 26
China gene editing startup YolTech raises $70M to move CRISPR therapies forward
endpoints
May 13, 26
#ASGCT26: After an apparent cure, a gene editing company struggles to repeat the magic
endpoints
May 13, 26
#ASGCT26: Tessera reveals strongest data yet for in vivo sickle cell therapy
endpoints
May 13, 26
STAT+: Drug meant to make gene therapy safer may also make it less effective
stat
May 13, 26
STAT+: Scientists link boy’s tumor to gene therapy viruses, in rare finding
stat
May 12, 26
STAT+: Capsida says it still doesn’t know what caused gene therapy death
stat
May 11, 26
STAT+: Five years after disaster, a rare disease community gets new chance at treatment
stat
May 8, 26
UT MD Anderson Shares Latest Research Breakthroughs
onclive
May 5, 26
Vertex earnings get muted investor response
biopharma dive
Apr 29, 26
STAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survive
stat
Apr 29, 26
Chiesi to buy KalVista in $1.9B deal for rare disease drug
biopharma dive
Apr 29, 26
FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
biopharma dive
Apr 29, 26
STAT+: Pharmalittle: We’re reading about the FDA speeding up trials, a Supreme Court hearing on ‘skinny labels,’ and more
stat
Apr 28, 26
STAT+: AIDS group sues Trump administration over undisclosed agreement with Gilead
stat
Apr 28, 26
STAT+: Supreme Court to hear case about ‘skinny labeling’ and generic access
stat
Apr 28, 26
STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
stat
Apr 28, 26
STAT+: Pharmalittle: We’re reading about warnings over Trump’s MFN plan, Purdue Pharma sentencing, and more
stat
Apr 28, 26
Lilly strikes second partnership this year for recombinase-based gene editing
endpoints
Apr 28, 26
STAT+: Eli Lilly enlists AI startup for next-generation gene editors
stat
← prev
page 3 of 4
next →
